AFINITOR vs LORBRENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. AFINITOR and LORBRENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AFINITOR	LORBRENA
Rating	70/100	64/100
Pharmacy pays	~$229.16 /30	—
Type	RX	RX
Active ingredient	EVEROLIMUS	LORLATINIB
Manufacturer	Novartis	Pfizer
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Half-life	about 30 hours (mean terminal elimination half-life)	—

afinitor lorbrena

Rating

70/100

64/100

Pharmacy pays

~$229.16 /30

—

Type

Active ingredient

EVEROLIMUS

LORLATINIB

Manufacturer

Novartis

Pfizer

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Half-life

about 30 hours (mean terminal elimination half-life)

—

Frequently asked questions

Which is better-rated, Afinitor or Lorbrena?

By our independent rating, Afinitor scores higher — 3.5 vs 3.2 out of 5 for Lorbrena. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Afinitor and Lorbrena?

Afinitor contains Everolimus, while Lorbrena contains Lorlatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.